Collectively, we revealed that FTO drives lung cancer progression via m6A‐dependent sequestration of IGFBP3 mRNA into P‐bodies by IMP3, which suppresses translation and activates AKT signalling. This evidence concerns the gene IMP3 and lung carcinoma.